Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	573.63	44.02	6.53
Graham Fair Price	-60.39	1882.89	4753.22
PEG	8097.45	0.08	< 0.005
Price/Book	3.71	0.60	0.58
Price/Cash Flow	109.04	-5.85	2.80
Prices/Earnings	542.19	-9.35	1.46
Price/Sales	65.67	0.92	0.56
Price/FCF	109.04	-5.85	2.80
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-17.27	0.38	0.46
Operating Margin	-86.62	-0.02	0.14
ROA	-84.53	< 0.005	0.04
ROE	0.10	-0.02	-83.85
ROIC	0.06	< 0.005	-93.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.14	-0.04	223.78
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	19.82	-1.08	-94.54
EPS QOQ	14.80	-1.16	-92.17
FCF QOQ	4.52	-1.49	-67.09
Revenue QOQ	0.49	-0.38	-21.05
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	106.41	171.43	61.10
Days Sales Outstanding (DSO)	23.99	33.89	41.28
Inventory Turnover	0.85	0.52	-37.93
Debt/Capitalization	0.46	0.50	9.54
Quick Ratio	0.80	0.83	4.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3181.02	3135.61	-1.43
Cash	1889.79	1943.26	2.83
Capex	-142.24	-77.93	45.21
Free Cash Flow	656.97	-321.29	-51.09
Revenue	3306.35	2040.26	-38.29
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.42	1.58	11.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.57	27.87	680.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating